Published November 2015
| Version v1
Journal article
The advantage and risk of 131I treatment in hyperthyroidism combined with liver injury or blood cell reduction
Creators
- 1. Department of Nuclear Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou (China)
Description
At present, anti-thyroid drugs, radioactive iodine(131I) and surgical therapy were considered as the three major methods for hyperthyroidism therapy. With the acceptance of the safety of 131I therapy in hyperthyroidism, more and more patients become to choose it as their therapeutic method, especially the patients with liver injury or blood cell reduction complications. This paper summaries the advantages and risks of 131I therapy in this two special hyperthyroidism patients groups according to the recent paper and clinical practice. (authors)
Additional details
Identifiers
Publishing Information
- Journal Title
- International Journal of Radiation Medicine and Nuclear Medicine
- Journal Volume
- 39
- Journal Issue
- 6
- Journal Page Range
- p. 483-486, 492
- ISSN
- 1673-4114
INIS
- Country of Publication
- China
- Country of Input or Organization
- China
- INIS RN
- 51068394
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BLOOD CELLS; HYPERTHYROIDISM; INJURIES; IODINE 131; LIVER; PATIENTS; RADIOTHERAPY; SURGERY; THYROID
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BIOLOGICAL MATERIALS; BLOOD; BODY; BODY FLUIDS; DAYS LIVING RADIOISOTOPES; DIGESTIVE SYSTEM; DISEASES; ENDOCRINE DISEASES; ENDOCRINE GLANDS; GLANDS; INTERMEDIATE MASS NUCLEI; IODINE ISOTOPES; ISOTOPES; MATERIALS; MEDICINE; NUCLEAR MEDICINE; NUCLEI; ODD-EVEN NUCLEI; ORGANS; RADIOISOTOPES; RADIOLOGY; THERAPY
Optional Information
- Notes
- 37 refs.; http://dx.doi.org/10.3760/cma.j.issn.1673-4114.2015.06.010